Predictive value of combined Albumin-Globulin score and psoas muscle index for postoperative prognosis in combined hepatocellular carcinoma and cholangiocarcinoma

联合白蛋白-球蛋白评分和腰大肌指数对合并肝细胞癌和胆管癌术后预后的预测价值

阅读:1

Abstract

BACKGROUND: Nutrition and inflammation play vital roles in the prognosis of cancer patients. This study evaluated the impact of relevant indicators-albumin-globulin score (AGS), psoas muscle index (PMI), and the combination of AGS and PMI (CAP)- on postoperative outcomes in combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) patients. METHODS: One hundred forty one cHCC-CC patients treated surgically from 2010 to 2020 were retrospectively analyzed. Psoas muscle area was measured via abdominal CT scans. Albumin (ALB), globulin (GLB), and PMI cutoff values were established through receiver operating characteristic (ROC) curves. The influence of AGS, PMI, and CAP on cHCC-CC prognosis was evaluated using Time-dependent ROC curves. The predictive accuracy of nomograms were evaluated using calibration plots, the C-index value, and the area under the ROC curves (AUC). RESULTS: Lower PMI and higher AGS indicated poorer OS and DFS. A lower CAP grade was linked to a more favorable prognosis, with CAP grade 1 showing the best and grade 3 the worst prognosis. The Td-ROC curve demonstrates that CAP grade outperforms PMI and AGS in terms of predictive ability at various time points. The predictive accuracy of nomograms was considered acceptable, with c-index values of 0.684 (95% CI: 0.632-0.731) and 0.684 (95% CI: 0.635-0.734) for OS and DFS, respectively.The corresponding AUC values for 1, 3, and 5-year OS were 0.731, 0.744, and 0.720, and for DFS were 0.768, 0.796, and 0.757. CONCLUSIONS: The CAP grade, integrating AGS and PMI, significantly correlates with postoperative prognosis in cHCC-CC patients. It stands as a crucial indicator for optimizing treatment planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。